Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for PIMAVANSERIN
- A Study of the Safety and Efficacy of Pimavanserin in Patients With Parkinson's Disease Psychosis
- Pimavanserin for Rigid-compulsive Symptoms in Autism Spectrum Disorder
- Pimavanserin and Aggression and Social Cognition.
- Pimavanserin for Sleep in Parkinson Disease
- Comparing Antipsychotic Medications in LBD Over Time
- Extension Study of Pimavanserin in Irritability Associated With Autism Spectrum Disorder
- Pimavanserin for the Treatment of Irritability Associated With Autism Spectrum Disorder
- Pimavanserin for Insomnia in Veterans With PTSD
- Characterization of the Serotonin 2A Receptor Selective PET Tracer [18F]MH.MZ in Patients With Neurodegenerative Diseases
- Pimavanserin for Insomnia in Veterans With Posttraumatic Stress Disorder: Proof of Concept
- Pimavanserin Treatment in TS
- Efficacy and Safety of Pimavanserin as Adjunctive Treatment for the Negative Symptoms of Schizophrenia
- Pimavanserin vs. Quetiapine for the Treatment Parkinson's Psychosis
- Open-Label Study With Pimavanserin on Activities of Daily Living in Subjects With Parkinson's Disease Psychosis
- Pimavanserin for Insomnia In Veterans With Posttraumatic Stress Disorder
- Study to Evaluate Safety and Daytime Sedation in Subjects With Parkinson's Disease With Neuropsychiatric Symptoms Treated With Pimavanserin or Low-Dose Quetiapine
- Extension Study of Pimavanserin in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Treatment
- Study to Evaluate the Efficacy and Safety of Adjunctive Pimavanserin in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Treatment (CLARITY-2)
- The Sub-Sero Study
- Study to Evaluate the Efficacy and Safety of Adjunctive Pimavanserin in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Treatment (CLARITY-2)
- Randomized Placebo Controlled Trial Evaluating the Efficacy of Pimavanserin, a Selective Serotonin 5-HydroxyTryptamine-2A (5HT2A) Inverse Agonist, to Treat Impulse Control Disorders in Parkinson's Disease.
- SRC Inhibition as a Potential Target for Parkinson's Disease Psychosis
- Extension Study of Pimavanserin in Adult Subjects With Neuropsychiatric Symptoms Related to Neurodegenerative Disease
- A Safety Study of Pimavanserin in Adult and Elderly Subjects Experiencing Neuropsychiatric Symptoms Related to Neurodegenerative Disease
- Safety and Efficacy of Pimavanserin in Adults With Parkinson's Disease and Depression
- Relapse Prevention Study of Pimavanserin in Dementia-related Psychosis
- Extension Study of Pimavanserin for the Adjunctive Treatment of Schizophrenia
- A Study of Pimavanserin for the Treatment of Agitation and Aggression in Subjects With Alzheimer's Disease
- Study to Evaluate the Efficacy and Safety of Adjunctive Pimavanserin in Major Depressive Disorder (CLARITY)
- Study to Examine the Safety and Efficacy of Pimavanserin for the Treatment of Agitation and Aggression in Alzheimer's Disease (SERENE)
- Efficacy and Safety of Pimavanserin as Adjunctive Treatment for the Negative Symptoms of Schizophrenia (ADVANCE)
- Efficacy and Safety of Adjunctive Pimavanserin for the Treatment of Schizophrenia (ENHANCE-1)
- Expanded Access of Pimavanserin for Patients With PD Psychosis
- A Study of the Safety and Efficacy of Pimavanserin in Patients With Alzheimer's Disease Psychosis
- An Open-label Safety Study of Pimavanserin in Parkinson's Disease Patients
- A Study of the Safety and Efficacy of Pimavanserin in Patients With Parkinson's Disease Psychosis
- A Study of Safety and Efficacy of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psychosis
- A Study of the Safety and Tolerability of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psychosis
- A Study of the Safety and Efficacy of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psychosis
Clinical trials list
click for details